These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 20202123)
41. Deregulation of miRNA-181c potentially contributes to the pathogenesis of AD by targeting collapsin response mediator protein 2 in mice. Zhou H; Zhang R; Lu K; Yu W; Xie B; Cui D; Jiang L; Zhang Q; Xu S J Neurol Sci; 2016 Aug; 367():3-10. PubMed ID: 27423553 [TBL] [Abstract][Full Text] [Related]
42. Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β. Schonrock N; Humphreys DT; Preiss T; Götz J J Mol Neurosci; 2012 Feb; 46(2):324-35. PubMed ID: 21720722 [TBL] [Abstract][Full Text] [Related]
43. Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells. Yu D; Tolleson WH; Knox B; Jin Y; Guo L; Guo Y; Kadlubar SA; Ning B Biochem Pharmacol; 2015 Dec; 98(4):671-80. PubMed ID: 26428001 [TBL] [Abstract][Full Text] [Related]
44. The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells. Pink RC; Samuel P; Massa D; Caley DP; Brooks SA; Carter DR Gynecol Oncol; 2015 Apr; 137(1):143-51. PubMed ID: 25579119 [TBL] [Abstract][Full Text] [Related]
45. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease. Lei X; Lei L; Zhang Z; Zhang Z; Cheng Y Int J Clin Exp Pathol; 2015; 8(2):1565-74. PubMed ID: 25973041 [TBL] [Abstract][Full Text] [Related]
46. The Role of miR-137 in Neurodegenerative Disorders. Bodai L; Borosta R; Ferencz Á; Kovács M; Zsindely N Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000336 [TBL] [Abstract][Full Text] [Related]
47. The Role of miR-124 in Drosophila Alzheimer's Disease Model by Targeting Delta in Notch Signaling Pathway. Kong Y; Wu J; Zhang D; Wan C; Yuan L Curr Mol Med; 2015; 15(10):980-9. PubMed ID: 26592243 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells. Yu D; Green B; Tolleson WH; Jin Y; Mei N; Guo Y; Deng H; Pogribny I; Ning B Biochem Pharmacol; 2015 Nov; 98(1):215-23. PubMed ID: 26296572 [TBL] [Abstract][Full Text] [Related]
49. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy. Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108 [TBL] [Abstract][Full Text] [Related]
50. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077 [TBL] [Abstract][Full Text] [Related]
52. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients. Haenisch S; Zhao Y; Chhibber A; Kaiboriboon K; Do LV; Vogelgesang S; Barbaro NM; Alldredge BK; Lowenstein DH; Cascorbi I; Kroetz DL Neurobiol Dis; 2015 May; 77():127-40. PubMed ID: 25766675 [TBL] [Abstract][Full Text] [Related]
53. Regulation of BACE1 by miR-29a/b in a cellular model of Spinocerebellar Ataxia 17. Roshan R; Ghosh T; Gadgil M; Pillai B RNA Biol; 2012 Jun; 9(6):891-9. PubMed ID: 22664922 [TBL] [Abstract][Full Text] [Related]
54. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders. Panegyres PK; Zafiris-Toufexis K; Kakulas BA J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649 [TBL] [Abstract][Full Text] [Related]
55. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains. Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K Neuropathol Appl Neurobiol; 2013 Feb; 39(2):109-20. PubMed ID: 22582881 [TBL] [Abstract][Full Text] [Related]
56. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases. Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107 [TBL] [Abstract][Full Text] [Related]
57. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Zhong S; Li W; Chen Z; Xu J; Zhao J Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis. Morquette B; Juźwik CA; Drake SS; Charabati M; Zhang Y; Lécuyer MA; Galloway DA; Dumas A; de Faria Junior O; Paradis-Isler N; Bueno M; Rambaldi I; Zandee S; Moore C; Bar-Or A; Vallières L; Prat A; Fournier AE Brain; 2019 Oct; 142(10):2979-2995. PubMed ID: 31412103 [TBL] [Abstract][Full Text] [Related]
59. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease. Chang WS; Wang YH; Zhu XT; Wu CJ Med Sci Monit; 2017 Jun; 23():2721-2731. PubMed ID: 28578378 [TBL] [Abstract][Full Text] [Related]
60. A miRNA signature of prion induced neurodegeneration. Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]